Insider Transactions by Heyrman Reinilde

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
BLPHBellerophon Therapeutics, Inc.Heyrman ReinildeChief Clinical Dev. OfficerFeb 19, 2015Buy$12.001,50018,0009,483Feb 23, 2015, 09:40 PM